Cognizant Technology Solutions
CTSH
$55.35
+2.70%
Cognizant Technology Solutions is a multinational IT services provider offering consulting, technology, and business process outsourcing services, primarily serving enterprise clients in financial services, healthcare, and resources. It is a major player in the global IT services industry, leveraging a global delivery model with a large offshore workforce in India to provide cost-effective solutions. The company is currently navigating a challenging period marked by a significant stock price decline, driven by concerns over growth deceleration, margin pressures, and the broader impact of AI on traditional IT services. Recent news highlights a tech-led market rally, but Cognizant's performance has lagged, with investors debating its ability to adapt to the AI-driven transformation and regain momentum.…
CTSH
Cognizant Technology Solutions
$55.35
Investment Opinion: Should I buy CTSH Today?
Rating: Hold. Cognizant is a stock with a compelling valuation but significant structural challenges. The analyst consensus is 'Buy' with an average target of $63.10, implying 14% upside, but the wide range and recent underperformance suggest caution. The thesis is that the stock is undervalued on a forward PE of 8.8x, but the market is pricing in a decline in earnings that may or may not materialize.
Sign up to view all
CTSH 12-Month Price Forecast
The AI assessment is neutral with medium confidence. The stock is cheap on a forward basis, but the market is pricing in significant risks from AI disruption. The recent 34.8% monthly rebound suggests some investors see value, but the long-term trend is still down. If the company can demonstrate that AI is a growth opportunity, the stance would upgrade to bullish. Conversely, if revenue growth decelerates further, it would downgrade to bearish. The key is to monitor quarterly results and management commentary on AI strategy.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Cognizant Technology Solutions's 12-month outlook, with a consensus price target around $63.10 and implied upside of +14.0% versus the current price.
Average Target
$63.10
0 analysts
Implied Upside
+14.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$42 - $84
Analyst target range
Cognizant is covered by 25 analysts, with a consensus recommendation of 'Buy' and a mean rating of 2.17 (where 1 is Strong Buy and 5 is Sell). The average price target is $63.10, implying an upside of 14.0% from the current price of $55.35. The target range is wide, from a low of $42.00 to a high of $84.00, indicating significant uncertainty about the company's future performance. The high target assumes a successful AI transformation and margin expansion, while the low target reflects concerns about continued revenue deceleration and competitive pressures. Recent ratings have been mostly neutral, with a few upgrades like Wedbush moving to Outperform, but no major bullish or bearish shifts.
Bulls vs Bears: CTSH Investment Factors
Cognizant presents a classic value trap versus turnaround debate. The bull case rests on a compelling forward PE of 8.8x, a strong balance sheet, and a recent 34.8% monthly rebound, suggesting the market may have overcorrected. However, the bear case is formidable: a 41% relative underperformance over the past year, the existential threat of AI to traditional IT services, and a PEG ratio of 20.6 that implies the market expects minimal growth. The most critical tension is whether the low valuation is justified by structural decline or represents an opportunity for a recovery. If management can demonstrate that AI is a tailwind rather than a headwind, the stock could re-rate significantly; if not, the low multiple may persist or even compress further. Currently, the bearish evidence is slightly stronger given the persistent negative momentum and the industry-wide disruption, but the recent price action and analyst support suggest a potential inflection point.
Bullish
- Forward PE at 8.8x: The forward PE of 8.79x is a significant discount to the market and historical averages, suggesting the stock is undervalued if earnings hold. This low multiple provides a margin of safety and potential for multiple expansion if growth stabilizes.
- Analyst consensus is Buy: With 25 analysts, the consensus is 'Buy' (mean rating 2.17) and the average price target is $63.10, implying 14% upside from the current price of $55.35. This indicates that sell-side analysts see more upside than downside.
- Strong balance sheet: The debt-to-equity ratio is only 0.10, and the current ratio is 2.34, indicating a solid liquidity position. This financial stability provides flexibility for investments, buybacks, and weathering downturns.
- Recent momentum rebound: The stock has rallied 34.8% over the past month, from a low of $38.73 to $55.35, showing a strong recovery. This suggests that the worst may be over and investor sentiment is improving.
Bearish
- Severe 1-year underperformance: CTSH is down 22.9% over the past year, while the S&P 500 is up 18.2%, a relative underperformance of over 41%. This persistent weakness reflects deep-seated concerns about the company's growth prospects.
- AI disruption threat: The rise of AI poses a significant threat to traditional IT services, potentially reducing demand for manual coding and testing. The market is pricing in this risk, as evidenced by the stock's decline despite stable earnings.
- High PEG ratio: The PEG ratio is 20.6, indicating that the stock is expensive relative to its growth rate. This suggests that the market expects very low future growth, which could lead to further de-rating if growth disappoints.
- Inconsistent revenue growth: Revenue growth has been choppy, with Q3 2025 revenue slightly declining from Q2 2025. This inconsistency makes it difficult to forecast future performance and undermines confidence in a sustained recovery.
CTSH Technical Analysis
Cognizant's stock is in a pronounced downtrend over the past year, with a 1-year price change of -22.87%, significantly underperforming the S&P 500's +18.19% gain. The current price of $55.35 sits at 37.6% of its 52-week range (low $37.08, high $87.03), indicating the stock is near the lower end of its trading band, reflecting persistent selling pressure and a bearish sentiment. This positioning suggests the market is pricing in significant challenges, and the stock has yet to show signs of a durable bottom.
Beta
0.86
0.86x market volatility
Max Drawdown
-55.3%
Largest decline past year
52-Week Range
$37-$87
Price range past year
Annual Return
-22.9%
Cumulative gain past year
| Period | CTSH Return | S&P 500 |
|---|---|---|
| 1m | +34.8% | +0.3% |
| 3m | +5.6% | +4.0% |
| 6m | -32.5% | +8.3% |
| 1y | -22.9% | +20.2% |
| ytd | -31.9% | +9.6% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
CTSH Fundamental Analysis
Cognizant's revenue growth has been modest but positive, with Q1 2026 revenue of $5.413 billion, up 5.83% year-over-year, and a sequential improvement from Q4 2025's $5.333 billion. However, growth has been inconsistent, with Q3 2025 revenue of $5.415 billion showing a slight decline from Q2 2025's $5.245 billion, indicating a choppy trajectory. The company's revenue segments show Financial Services as the largest at $1.644 billion, followed by Healthcare at $1.579 billion, Products and Resources at $1.321 billion, and Communication, Media, and Technology at $0.869 billion, with no clear growth driver emerging.
Quarterly Revenue
$5.4B
2026-03
Revenue YoY Growth
+5.8%
YoY Comparison
Gross Margin
29.6%
Latest Quarter
Free Cash Flow
$2.5B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is CTSH Overvalued?
Given that Cognizant is profitable, the PE ratio is the primary valuation metric. The trailing PE is 18.20x, while the forward PE is 8.79x, a significant discount that implies the market expects a sharp decline in earnings, which is inconsistent with the consensus EPS estimate of $6.26 for the next fiscal year. The forward PE is based on the current price and estimated EPS, but the trailing PE reflects the last twelve months' earnings, which were boosted by one-time items, making the forward PE more indicative of future earnings power.
PE
18.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 11x~21x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
9.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial risks: Cognizant's revenue growth is modest at 5.8% YoY, but it has been inconsistent, with sequential declines in some quarters. The company's operating margin is 16.7%, which is under pressure from rising costs and investments in AI. While the balance sheet is strong (debt-to-equity of 0.10), the company's free cash flow of $2.47 billion is adequate but not growing significantly. The forward PE of 8.8x implies the market expects a sharp earnings decline, which could materialize if revenue growth stalls or margins compress further. The high PEG ratio of 20.6 suggests that the stock is not cheap relative to its growth, and any earnings miss could trigger a de-rating.